CargoAdmin, Bureaucrats, Moderators (CommentStreams), fileuploaders, Interface administrators, newuser, Push subscription managers, Suppressors, Administrators
14,662
edits
Blood Products Advisory Committee: Difference between revisions
m
Text replacement - "{{Organization" to "Catergory:Orgs {{Organization"
(Created page with "{{Organization |OrganizationName=Blood Products Advisory Committee |OrganizationType=Boards, Commissions, and Committees |Mission=The Blood Products Advisory Committee (BPAC) advises the FDA on the safety, effectiveness, and appropriate use of blood products. Its mission is to review and evaluate scientific data to ensure that blood, blood components, and related biological products meet rigorous standards for public health safety. |OrganizationExecutive=Designated Fede...") |
m (Text replacement - "{{Organization" to "Catergory:Orgs {{Organization") Tag: Reverted |
||
| Line 1: | Line 1: | ||
{{ | [[Catergory:Orgs]] | ||
|OrganizationName=Blood Products Advisory Committee | {{<span class="error">Expansion depth limit exceeded</span>|OrganizationName=Blood Products Advisory Committee | ||
|OrganizationType=Boards, Commissions, and Committees | |OrganizationType=Boards, Commissions, and Committees | ||
|Mission=The Blood Products Advisory Committee (BPAC) advises the FDA on the safety, effectiveness, and appropriate use of blood products. Its mission is to review and evaluate scientific data to ensure that blood, blood components, and related biological products meet rigorous standards for public health safety. | |Mission=The Blood Products Advisory Committee (BPAC) advises the FDA on the safety, effectiveness, and appropriate use of blood products. Its mission is to review and evaluate scientific data to ensure that blood, blood components, and related biological products meet rigorous standards for public health safety. | ||
| Line 18: | Line 18: | ||
'''Blood Products Advisory Committee (BPAC)''' is part of the U.S. Food and Drug Administration (FDA) and provides advice on matters related to blood, blood products, and biotechnological products intended for use in the diagnosis, prevention, or treatment of human diseases. The committee is based in Silver Spring, Maryland, and is tasked with ensuring the safety and efficacy of these products. | '''Blood Products Advisory Committee (BPAC)''' is part of the U.S. Food and Drug Administration (FDA) and provides advice on matters related to blood, blood products, and biotechnological products intended for use in the diagnosis, prevention, or treatment of human diseases. The committee is based in Silver Spring, Maryland, and is tasked with ensuring the safety and efficacy of these products. | ||
{{ | {{<span class="error">Expansion depth limit exceeded</span>|url=https://www.fda.gov/advisory-committees/blood-products-advisory-committee}} | ||
==Mission== | ==Mission== | ||
BPAC's mission is to advise the FDA on regulatory issues concerning blood products. This includes reviewing the safety, effectiveness, and appropriate use of blood products, considering labeling, clinical and laboratory studies, and research programs to support regulatory decisions.< | BPAC's mission is to advise the FDA on regulatory issues concerning blood products. This includes reviewing the safety, effectiveness, and appropriate use of blood products, considering labeling, clinical and laboratory studies, and research programs to support regulatory decisions.<span class="error">Expansion depth limit exceeded</span> | ||
==Parent organization== | ==Parent organization== | ||
| Line 74: | Line 74: | ||
==Services provided== | ==Services provided== | ||
BPAC provides recommendations on the approval, labeling, and post-marketing surveillance of blood products. It focuses on ensuring these products are safe and effective, considering the risks of transfusion-transmitted diseases and the quality of blood components.< | BPAC provides recommendations on the approval, labeling, and post-marketing surveillance of blood products. It focuses on ensuring these products are safe and effective, considering the risks of transfusion-transmitted diseases and the quality of blood components.<span class="error">Expansion depth limit exceeded</span> | ||
==Headquarters address== | ==Headquarters address== | ||
| Line 92: | Line 92: | ||
==References== | ==References== | ||
< | <span class="error">Expansion depth limit exceeded</span> | ||